Bioanalytical liquid chromatography-tandem mass spectrometric assay for the quantification of the ALK inhibitors alectinib, brigatinib and lorlatinib in plasma and mouse tissue homogenates
Posted by Leanne Kodsman on
Normal Single Donor Human Plasma from Innovative Research was recently used in the following study:
Journal of Pharmaceutical and Biomedical Analysis, August 2018
Bioanalytical liquid chromatography-tandem mass spectrometric assay for the quantification of the ALK inhibitors alectinib, brigatinib and lorlatinib in plasma and mouse tissue homogenates
Rolf W. Sparidans, Wenlong Li, Alfred H. Schinkel, Jan H.M. Schellens, Jos H. BeijnenJournal of Pharmaceutical and Biomedical Analysis, August 2018
" ... Several second and third generation ALK inhibitors have been introduced in recent years. A bioanalytical assay for simultaneous quantification of alectinib, brigatinib, and lorlatinib was developed and validated for human plasma. The method was also partially validated for diluted mouse plasma and tissue homogenates of brain, liver, kidney, and spleen ... plasma of individual humans was provided by Innovative Research (Novi, MI, USA). "
Related products available from Innovative Research also include:
The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!
Related Posts
Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
In the ever-evolving landscape of molecular biology, precision tools are essential for ...
Read the ArticleRevolutionizing Diabetes Treatment: Genetically Engineered Pseudo-Islets Achieve Insulin Independence
In a groundbreaking study, researchers have pioneered a diabetes treatment that could r...
Read the ArticlePioneering Advances in Complement-Mediated Disorders: An In-depth Look at SAR443809
In the dynamic landscape of medical research, SAR443809 emerges as a promising candidat...
Read the Article